Unterehmen auf Watchlist setzen
Hypha Labs, Inc.
ISIN: US2538252022
WKN: A14TYC
Über
Unternehmensprofil
Tipp: Investor-Alerts aktivieren
Lassen Sie sich bei neuen Publikationen informieren
Tipp: AI-Factsheet

Corporate News meets AI! 
Analyse der Inhalte und Zusammenfassung

Hypha Labs · ISIN: US2538252022 · ACCESSWIRE (ID: 918586)
23 November 2024 02:25AM

Hypha Labs, Inc. Uplists to the OTCQB


OTCQB Listing Brings Transparency, Prestige and Beneficial Exposure

LAS VEGAS, NV / ACCESSWIRE / September 16, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences, is pleased to announce that the Company has commenced trading on the OTCQB, a premier market operated by OTC Markets Group, Inc., created for developing and entrepreneurial companies in the United States and abroad. Listing on the OTCQB provides better companies with amplified market visibility to enhance trading liquidity, credibility and introduction to a broader class of investors and institutions.

OTCQB companies are required to be current in their financial reporting with the Securities and Exchange Commission (the "SEC") or OTC Markets Group, Inc., maintain audited financials through a qualified PCAOB registered firm, undergo company verification and management certification on an annual basis, and exceed a minimum bid price test.

Hypha Labs trades under the ticker "FUNI" and began trading on the OTCQB® Venture Market (the "OTCQB") effective September 16, 2024 at the market's open.

"Trading on the OTCQB is both a testament to our perseverance and organization as well as a catalyst to greater exposure to investors of all variety," stated Stone Douglass, CEO, Hypha Labs. "It is essential that we are able to celebrate the successes we expect to come with the release of what we believe will be the finest in-home and commercial manufacturer of better mushroom ingredients on the market."

About Hypha Labs, Inc.

The company has developed revolutionary cutting-edge technology focused on new methods of producing the active ingredients found in functional mushrooms such as psilocybin using its patent-pending bioreactor design. The Company has positioned itself to play an important role in the burgeoning Functional Mushroom industry in addition to being a disruptive force in the psilocybin space which is quickly manifesting into a similar pattern that was seen in the Cannabis Industry both from a medical and recreational usage with several states and cities have now decriminalized it use. Visit us at HyphaLabs.com.

SAFE HARBOR FORWARD LOOKING STATEMENTS:

This press release may contain forward looking statements that are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues related to our financial performance, expected revenue, contracts, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC) and on the OTC Disclosure & News Service (OTCDNS). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the SEC and/or OTCDNS. Among other matters, the Company may not be able to sustain growth or achieve profitability based upon many factors including but not limited to the risk that we will not be able to find and secure construction contracts and the necessary assets that will enable us to become profitable. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC and/or OTCDNS filings. We have incurred and will continue to incur significant expenses in our development stage, noting that there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. New lines of business in the construction industry may expose us to additional legal and regulatory costs and unknown exposure(s), the impact of which cannot be predicted at this time. Words such as "estimate," "project," "predict," "will," "would," "should," "could," "may," "might," "anticipate," "plan," "intend," "believe," "expect," "aim," "goal," "target," "objective," "likely" or similar expressions that convey the prospective nature of events or outcomes generally indicate forward-looking statements. You should not place undue reliance on these forward-looking statements, which speak only as of this press release. Unless legally required, we undertake no obligation to update, modify or withdraw any forward-looking statements, because of new information, future events or otherwise.

From time to time, the Company may post new and material information on its website or through its social media profiles at the links below:

LN: https://www.linkedin.com/company/hypha-labs-inc/
FB: https://www.facebook.com/hyphalabs
IG: https://www.instagram.com/hyphalabsinc/
Twitter: https://x.com/Hypha_Labs

For more information about Hypha Labs visit HyphaLabs.com

Investor and Media Relations:

Integrity Media Inc.
(888) 216-3595
team@integritymedia.com

SOURCE: Hypha Labs, Inc.



View the original press release on accesswire.com

Visuelle Wertentwicklung / Kursverlauf · Hypha Labs
Smarte Analyse- und Recherchewerkzeuge finden Sie hier.
Diese Publikation wurde durch unseren Content-Partner ACCESSWIRE zur Verfügung gestellt
AccessWire
via AccessWire - Newsfeed
  ©2024
News Distribution Services
Kontakt:
1 Glenwood Ave, Suite 1001 Raleigh, NC 27603
+‍866.405.3096